Abstract
IMPORTANCE Olfactory dysfunction is among the earliest signs of many age-related neurodegenerative diseases and has been associated with increased mortality in older adults; however, its genetic basis remains largely unknown.
OBJECTIVE To identify the genetic loci associated with olfactory dysfunction in the general population.
DESIGN, SETTING AND PARTIICIPANTS This genome-wide association study meta-analysis (GWMA) included participants of European ancestry (N = 22,730) enrolled in four different large population-based studies, followed by a multi-ancestry GWMA including participants of African ancestry (N = 1,030). The data analysis was performed from March 2023 through June 2024.
EXPOSURES Genome-wide single nucleotide polymorphisms.
MAIN OUTCOMES AND MEASURES Olfactory dysfunction was the outcome and assessed using a 12-item smell identification test.
RESULTS GWMA revealed a novel genome-wide significant locus (tagged by rs11228623 at 11q12) associated with olfactory dysfunction. Gene-based analysis revealed a high enrichment for olfactory receptor genes in this region. Phenome-wide association studies demonstrated associations between genetic variants related to olfactory dysfunction and blood cell counts, kidney function, skeletal muscle mass, cholesterol levels and cardiovascular disease. Using individual-level data, we also confirmed and quantified the strength of these associations on a phenotypic level. Moreover, employing two-sample Mendelian Randomization analyses, we found evidence for causal associations between olfactory dysfunction and these phenotypes.
CONCLUSIONS These findings provide novel insights into the genetic architecture of the sense of smell and highlight its importance for many aspects of human health.
Question What is the genetic basis of olfactory dysfunction, and is it causally related to adverse health outcomes?
Findings This genome-wide association study meta-analysis (GWMA) of 22,730 European and 1,030 African participants identified a novel genomic locus, enriched for olfactory receptor genes, robustly associated with olfactory dysfunction. Two-sample Mendelian Randomization analyses provided evidence for causal associations of olfactory dysfunction with biochemical, anthropometric and cardiovascular health outcomes.
Meaning These findings provide new insights into the genetic architecture of olfaction and implicate olfactory dysfunction as a causal risk factor for many aspects of human health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors thank the staff and participants of all the participating cohort studies for their important contributions. The Rhineland Study is supported by DZNE core funding at the German Center for Neurodegenerative Diseases (DZNE). This work was further supported by the Federal Ministry of Education and Research (BMBF) as part of the Diet-Body-Brain Competence Cluster in Nutrition Research. N.A. Aziz is partly supported by an Alzheimer's Association Research Grant (Award Number: AARG-19-616534) and a European Research Council Starting Grant (Number: 101041677). The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, 75N92022D00005).LIFE-Adult is funded by the Leipzig Research Center for Civilization Diseases (LIFE). LIFE is an organizational unit affiliated to the Medical Faculty of the University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by funds of the Free State of Saxony within the framework of the excellence initiative. The CHRIS study is conducted in collaboration between the Eurac Research Institute for Biomedicine and the Healthcare System of the Autonomous Province of Bolzano-South Tyrol. Investigators thank all study participants and general practitioners of the Vinschgau/Val Venosta district, and Schlanders/Silandro and Autonomous Province of Bolzano-South Tyrol Healthcare System staff for their support and collaboration
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Rhineland Study data on which this manuscript was based, are not publicly available due to data protection regulations. Access to data can be provided to scientists in accordance with the Rhineland Study Data Use and Access Policy. Data of LIFE-Adult are available in the framework of project agreements based on written requests. CHRIS data can be requested for research purposes by submitting a dedicated request to the CHRIS Access Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The Rhineland Study data on which this manuscript was based, are not publicly available due to data protection regulations. Access to data can be provided to scientists in accordance with the Rhineland Study Data Use and Access Policy. Data of LIFE-Adult are available in the framework of project agreements based on written requests. CHRIS data can be requested for research purposes by submitting a dedicated request to the CHRIS Access Committee.
